Filing Details

Accession Number:
0001209191-10-023695
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-26 13:00:00
Reporting Period:
2010-04-22
Filing Date:
2010-04-26
Accepted Time:
2010-04-26 17:48:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1254419 Medassets Inc MDAS Services-Prepackaged Software (7372) 510391128
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1058190 F Bruce Wesson C/O Galen Management, L.l.c.
680 Washington Blvd.
Stamford CT 06901
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-04-22 29,700 $22.11 5,787,499 No 4 S Indirect See FN
Common Stock Disposition 2010-04-23 61,600 $22.14 5,725,899 No 4 S Indirect See FN
Common Stock Disposition 2010-04-26 20,408 $22.71 5,705,491 No 4 S Indirect See FN
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See FN
No 4 S Indirect See FN
No 4 S Indirect See FN
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 54,783 Direct
Footnotes
  1. The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Funds on September 1, 2009
  2. The shares were sold as follows: 5,224 by Galen Partners IV, L.P. ("Galen IV"), 415 shares by Galen Partners International IV, L.P. ("Galen International IV"), 7 by Galen Employee Fund IV, L.P. ("Employee Fund IV"), 21,986 by Galen Partners III, L.P. ("Galen III"), 1,992 by Galen Partners International III, L.P. ("Galen International III") and 76 shares by Galen Employee Fund III, L.P. ("Employee Fund III" and, collectively with Galen IV, Galen International IV, Employee Fund IV, Galen III, Galen International III, the "Funds").
  3. The shares were sold at prices between $22.06 and $22.22. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. The shares are held as follows: 1,017,391 by Galen IV, 80,818 by Galen International IV, 1,418 by Employee Fund IV, 4,281,478 by Galen III, 388,016 by Galen International III and 18,378 by Employee Fund III. Claudius IV, L.L.C. ("Claudius IV") serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
  5. Claudius, L.L.C. ("Claudius") serves as the sole General Partner of Galen III and Galen International III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. The Reporting Person is a member of Claudius IV, a member of Claudius and the sole shareholder of Wesson Enterprises. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest therein.
  6. The shares were sold as follows: 10,835 shares by Galen IV, 861 shares by Galen International IV, 15 shares by Employee Fund IV, 45,599 shares by Galen III, 4,133 shares by Galen International III and 157 shares by Employee Fund III.
  7. The shares were sold at prices between $22.06 and $22.26. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  8. The shares are held as follows: 1,006,556 by Galen IV, 79,957 by Galen International IV, 1,403 by Employee Fund IV, 4,235,879 by Galen III, 383,883 by Galen International III and 18,221 by Employee Fund III. Claudius IV serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
  9. The shares were sold as follows: 3,591 shares by Galen IV, 284 shares by Galen International IV, 6 shares by Employee Fund IV, 15,107 shares by Galen III, 1,369 shares by Galen International III and 51 shares by Employee Fund III.
  10. The shares were sold at prices between $22.54 and $22.96. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  11. The shares are held as follows: 1,002,965 by Galen IV, 79,673 by Galen International IV, 1,397 by Employee Fund IV, 4,220,772 by Galen III, 382,514 by Galen International III and 18,170 by Employee Fund III. Claudius IV serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.